Prize-Based Incentives for Smoking Cessation Among People With HIV: A Sequential Multiple Assignment Randomized Trial

被引:2
|
作者
Ledgerwood, David M. [1 ]
Lundahl, Leslie H. [1 ]
Greenwald, Mark K. [1 ]
Cohn, Jonathan [2 ]
Arfken, Cynthia L. [1 ]
机构
[1] Wayne State Univ, Dept Psychiat & Behav Neurosci, Ste 2C,3901 Chrysler Dr, Detroit, MI 48201 USA
[2] Wayne State Univ, Dept Internal Med, Div Infect Dis, Detroit, MI 48201 USA
关键词
QUALITY-OF-LIFE; CONTINGENCY MANAGEMENT; TOBACCO USE; SMOKERS; INTERVENTIONS; ABSTINENCE; DEPENDENCE; VARENICLINE; EFFICACY; USERS;
D O I
10.1093/ntr/ntae243
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Contingency management (CM) is an incentive-based approach that has demonstrated efficacy for smoking cessation in various populations. There is an unmet need for feasible and effective smoking cessation interventions in people with HIV (PWH). The purpose of this study was to assess the efficacy of prize-based CM for smoking cessation in PWH using a Sequential Multiple Assignment Randomization Trial (SMART) design selected to tailor intervention intensity based on early treatment response. Methods: During phase I, 129 participants were randomly assigned to high-magnitude prize CM (HM-CM) or standard of care (SoC) for 4 weeks. Participants who did not reduce smoking were randomized in phase II to continued counseling with HM-CM plus monitoring support or only continued monitoring support for 8 weeks. Participants who reduced smoking were randomized to booster monitoring with low-magnitude CM or no additional care. Outcomes were biochemically verified smoking reduction and 7-day abstinence prevalence at posttreatment, 6-month, and 12-month follow-up. Results: Phase I responders (based on biochemical indicators of smoking reduction) were significantly less likely to return to smoking (during treatment and at 6 and 12 months) if they received low-magnitude incentives. Notably, initial exposure to CM versus SoC did not increase the rate of phase I response, and high-magnitude incentives later in treatment did not lead to greater smoking cessation for early-treatment nonresponders. Conclusions: Weekly CM sessions in the first 4 weeks of smoking cessation intervention did not perform significantly better than SoC. However, brief booster CM sessions aimed at maintaining early smoking cessation hold clinical promise and warrant further investigation. Implications: This represents the first trial to examine the use of CM for smoking cessation among PWH within the context of a SMART design.
引用
收藏
页码:893 / 902
页数:10
相关论文
共 50 条
  • [11] A sequential multiple assignment randomized trial for cocaine cessation and relapse prevention: Tailoring treatment to the individual
    Schmitz, Joy M.
    Stotts, Angela L.
    Vujanovic, Anka A.
    Weaver, Michael F.
    Yoon, Jin H.
    Vincent, Jessica
    Green, Charles E.
    CONTEMPORARY CLINICAL TRIALS, 2018, 65 : 109 - 115
  • [12] Financial Incentives for Smoking Cessation in Hospitalized Patients: A Randomized Clinical Trial
    Ladapo, Joseph A.
    Tseng, Chi-Hong
    Sherman, Scott E.
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (06) : 741 - 749
  • [13] A randomized, controlled trial of combined cognitive-behavioral therapy plus prize-based contingency management for cocaine dependence
    Petitjean, Sylvie A.
    Duersteler-MacFarland, Kenneth M.
    Krokar, Marina Croquette
    Strasser, Johannes
    Mueller, Sandra E.
    Degen, Bigna
    Trombini, Mauro V.
    Vogel, Marc
    Walter, Marc
    Wiesbeck, Gerhard A.
    Farronato, Nadine S.
    DRUG AND ALCOHOL DEPENDENCE, 2014, 145 : 94 - 100
  • [14] Evaluation of an integrated treatment to address smoking cessation and anxiety/depressive symptoms among people living with HIV: Study protocol for a randomized controlled trial
    Garey, Lorra
    Wirtz, Megan R.
    Labbe, Allison K.
    Zvolensky, Michael J.
    Smits, Jasper A. J.
    Giordano, Thomas P.
    Rosenfield, David
    Robbins, Gregory K.
    Levy, Douglas E.
    McKetchnie, Samantha M.
    Bell, Tanisha
    O'Cleirigh, Conall
    CONTEMPORARY CLINICAL TRIALS, 2021, 106
  • [15] Optimizing Longitudinal Tobacco Cessation Treatment in Lung Cancer Screening A Sequential, Multiple Assignment, Randomized Trial
    Fu, Steven S.
    Rothman, Alexander J.
    Vock, David M.
    Lindgren, Bruce R.
    Almirall, Daniel
    Begnaud, Abbie
    Melzer, Anne C.
    Schertz, Kelsey L.
    Branson, Mariah
    Haynes, David
    Hammett, Patrick
    Joseph, Anne M.
    JAMA NETWORK OPEN, 2023, 6 (08) : E2329903
  • [16] Program for lung cancer screening and tobacco cessation: Study protocol of a sequential, multiple assignment, randomized trial
    Fu, Steven S.
    Rothman, Alexander J.
    Vock, David M.
    Lindgren, Bruce
    Almirall, Daniel
    Begnaud, Abbie
    Melzer, Anne
    Schertz, Kelsey
    Glaeser, Susan
    Hammett, Patrick
    Joseph, Anne M.
    CONTEMPORARY CLINICAL TRIALS, 2017, 60 : 86 - 95
  • [17] Race/ethnicity-based discrimination, depressive symptoms, and smoking-related variables among people with HIV participating in a randomized clinical trial for cigarette smoking cessation
    Agterberg, Silvana
    Shuter, Jonathan
    Stanton, Cassandra A.
    Seng, Elizabeth K.
    Weinberger, Andrea H.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2024, 36 (12): : 1781 - 1794
  • [18] Randomized trial of prize-based reinforcement density for simultaneous abstinence from cocaine and heroin
    Ghitza, Udi E.
    Epstein, David H.
    Schmittner, John
    Vahabzadeh, Massoud
    Lin, Jia-Ling
    Preston, Kenzie L.
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2007, 75 (05) : 765 - 774
  • [19] Commitment Contracts and Team Incentives A Randomized Controlled Trial for Smoking Cessation in Thailand
    White, Justin S.
    Dow, William H.
    Rungruanghiranya, Suthat
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2013, 45 (05) : 533 - 542
  • [20] Community-based smoking cessation treatment for adults with high anxiety sensitivity: a randomized clinical trial
    Smits, Jasper A. J.
    Zvolensky, Michael J.
    Rosenfield, David
    Brown, Richard A.
    Otto, Michael W.
    Dutcher, Christina D.
    Papini, Santiago
    Freeman, Slaton Z.
    DiVita, Annabelle
    Perrone, Alex
    Garey, Lorra
    ADDICTION, 2021, 116 (11) : 3188 - 3197